# Lamotrigine for Ketamine Dependence Trial

> **NCT02556060** · PHASE2,PHASE3 · COMPLETED · sponsor: **Taipei City Hospital** · enrollment: 30 (actual)

## Conditions studied

- Addiction

## Interventions

- **DRUG:** Lamotrigine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02556060
- **Lead sponsor:** Taipei City Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2017-05-01
- **Final completion:** 2017-05-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02556060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02556060, "Lamotrigine for Ketamine Dependence Trial". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02556060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*